Search

Search Constraints

You searched for: Author/Creator Slim, Najla

Search Results

1. A TCP-based early regression index predicts the pathological response in neo-adjuvant radio-chemotherapy of rectal cancer. Issue 3 (September 2018)

2. Accurate outcome prediction after neo-adjuvant radio-chemotherapy for rectal cancer based on a TCP-based early regression index. (November 2019)

3. Assessment and clinical validation of margins for adaptive simultaneous integrated boost in neo-adjuvant radiochemotherapy for rectal cancer. Issue 2 (March 2015)

4. Definitions and treatment of oligometastatic oesophagogastric cancer according to multidisciplinary tumour boards in Europe. (March 2022)

5. Early variation of 18-fluorine-labelled fluorodeoxyglucose PET-derived parameters after chemoradiotherapy as predictors of survival in locally advanced pancreatic carcinoma patients. Issue 10 (October 2019)

6. External validation of a composite bio-humoral index in anal cancer patients undergoing concurrent chemoradiation. (December 2022)

7. Impact of molecular subtype on 1325 early-stage breast cancer patients homogeneously treated with hypofractionated radiotherapy without boost: Should the indications for radiotherapy be more personalized?. (February 2021)

8. Predicting pathological response after radio-chemotherapy for rectal cancer: Impact of late oxaliplatin administration. (August 2020)

9. Tailoring the radiotherapy approach in patients with anal squamous cell carcinoma based on inguinal sentinel lymph node biopsy. Issue 1 (22nd September 2020)